Active ingredientNepafenacCat. No. P-N036-001CAS 78281-72-8Family · Pharmaceutical analytical standards
Nepafenac
A non-steroidal anti-inflammatory eye drop, approved in the United States in 2005 for pain and inflammation after cataract surgery; in Europe it is also indicated to reduce the risk of macular oedema in diabetic patients. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?It is a prodrug: it crosses the cornea and only inside the eye is it converted by enzymes of the ocular tissues into amfenac, its active form.
Go to the active ingredient →Active ingredientNepafenacCat. No. P-N036-001CAS 78281-72-8
Isotopically labelledNepafenac-d5Cat. No. P-N036-002CAS 1246814-53-8
Impurity(2-aminophenyl)(phenyl)methanoneCat. No. P-N036-003CAS 2835-77-0
ImpurityNepafenac Impurity 1Cat. No. P-N036-004CAS 78281-71-7
ImpurityNepafenac Impurity BCat. No. P-N036-005CAS 78281-61-5
Impurity2-amino-3-benzoylbenzoicacidCat. No. P-N036-006CAS 98790-48-8
ImpurityNepafenac Impurity ECat. No. P-N036-007CAS 1246956-18-2
Impurity8-benzoyl-1,2-dihydrocinnolin-3(4H)-oneCat. No. P-N036-008CAS 1881270-49-0
ImpurityNepafenac Impurity 2Cat. No. P-N036-009CAS 1881270-50-3
ImpurityNepafenac Impurity 3Cat. No. P-N036-010CAS 1881270-51-4
ImpurityThionepafenacCat. No. P-N036-011CAS 173262-94-7No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.